NeuroPace Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Joel Becker
Chief executive officer
US$1.8m
Total compensation
| CEO salary percentage | 13.9% |
| CEO tenure | 1.5yrs |
| CEO ownership | n/a |
| Management average tenure | 1.5yrs |
| Board average tenure | 3.5yrs |
Recent management updates
Recent updates
After Leaping 90% NeuroPace, Inc. (NASDAQ:NPCE) Shares Are Not Flying Under The Radar
Dec 04
Here's What Analysts Are Forecasting For NeuroPace, Inc. (NASDAQ:NPCE) After Its Third-Quarter Results
Nov 14Does NeuroPace (NASDAQ:NPCE) Have A Healthy Balance Sheet?
Nov 07NeuroPace, Inc. (NASDAQ:NPCE) Screens Well But There Might Be A Catch
Aug 03Is NeuroPace (NASDAQ:NPCE) Weighed On By Its Debt Load?
Apr 12NeuroPace: Picking Up The Pace
Feb 25Why Investors Shouldn't Be Surprised By NeuroPace, Inc.'s (NASDAQ:NPCE) 58% Share Price Surge
Jan 22NeuroPace, Inc. (NASDAQ:NPCE) Stock Rockets 39% But Many Are Still Ignoring The Company
Apr 17NeuroPace announces U.S. distribution agreement with DIXI Medical
Aug 11NeuroPace EPS misses by $32.45, beats on revenue; issues guidance
Jun 03CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$28m |
| Jun 30 2024 | n/a | n/a | -US$30m |
| Mar 31 2024 | n/a | n/a | -US$32m |
| Dec 31 2023 | US$2m | US$248k | -US$33m |
Compensation vs Market: Joel's total compensation ($USD1.79M) is about average for companies of similar size in the US market ($USD2.26M).
Compensation vs Earnings: Insufficient data to compare Joel's compensation with company performance.
CEO
Joel Becker (56 yo)
1.5yrs
Tenure
US$1,785,337
Compensation
Mr. Joel D. Becker serves as CEO & Director of at NeuroPace, Inc. since July 10, 2023 and serves as its President. He had been President of Cardiac Rhythm Management & Neuromodulation at Integer Holdings C...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 1.5yrs | US$1.79m | no data | |
| CFO, VP of Finance & Administration | 24.7yrs | US$994.91k | 0.17% $ 596.0k | |
| Chief Medical Officer | 20.5yrs | US$1.11m | 0.45% $ 1.6m | |
| Chief of Operations & Development | less than a year | no data | no data | |
| General Counsel & Corporate Secretary | less than a year | no data | no data | |
| Vice President of Sales | 1.7yrs | no data | no data | |
| Vice President of Human Resources | less than a year | no data | no data |
1.5yrs
Average Tenure
63yo
Average Age
Experienced Management: NPCE's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 1.5yrs | US$1.79m | no data | |
| Independent Director | 28yrs | US$111.53k | 1.2% $ 4.3m | |
| Chairman of the Board | 27.2yrs | US$152.85k | 1.93% $ 6.9m | |
| Independent Director | 2yrs | US$218.80k | 0.019% $ 67.4k | |
| Director | no data | no data | no data | |
| Independent Director | 12yrs | US$124.03k | 0.14% $ 494.4k | |
| Board Observer | no data | no data | no data | |
| Independent Director | 3.2yrs | US$125.45k | 0% $ 0 | |
| Independent Director | 3.8yrs | US$126.53k | 0.025% $ 89.7k |
3.5yrs
Average Tenure
56yo
Average Age
Experienced Board: NPCE's board of directors are considered experienced (3.5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 05:15 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
NeuroPace, Inc. is covered by 10 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Polark | Baird |
| Ross Osborn | Cantor Fitzgerald & Co. |
| Robert Marcus | J.P. Morgan |